Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Conference News ESC 2023

ESC Endocarditis Guidelines Get First Update in 8 Years

Todd Neale

August 31, 2023

News Conference News AHA 2021

RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor

Yael L. Maxwell

November 13, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News EACTS 2021

More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients

Michael O'Riordan

October 18, 2021

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Daily News

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

Todd Neale

December 22, 2014

News Daily News

SMD frente a MIDCAB a los 10 Años: Resultados Similares en el Tratamiento de la Enfermedad de la Arteria Descendente Anterior Izda. y Mayor RVD con la PCI

Jason Kahn

January 24, 2013

News Daily News

BMS vs. MIDCAB at 10 Years: Results Similar for LAD Disease, TVR Higher with PCI

Jason Kahn

January 24, 2013

News Daily News

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

Jason Kahn

January 23, 2011

Advertisement

MACE in CV Trials: Has the Outcome Outlived Its Role?

Will Semaglutide Change Cardiac Surgery? It Already Has

ESC Endocarditis Guidelines Get First Update in 8 Years

RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

More Deaths With Bioprosthetic Than Mechanical AVR in Young AS Patients

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

SMD frente a MIDCAB a los 10 Años: Resultados Similares en el Tratamiento de la Enfermedad de la Arteria Descendente Anterior Izda. y Mayor RVD con la PCI

BMS vs. MIDCAB at 10 Years: Results Similar for LAD Disease, TVR Higher with PCI

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content